genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Videos
Webinars
eBooks
Podcasts
Events
New Products
Best of the Web
Best Apps
BioPerspectives
Subscribe
Create a Free Account
Log In
Get the GEN Mobile App
Get GEN Magazine
Get GEN eNewsletters
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
News
Simple Cocktail Converts Astrocytes to Neurons
News
AbbVie to Co-Develop Teneobio’s Lead Candidate for Multiple Myeloma, Gains Acquisition…
News
Studying Malaria Transcriptomics Directly from Patients
News
Heightened Cocaine Addiction and Motivation in Women Linked to Hormones
News
Tailored Cancer Drugs from New Cell Receptor Insights
Insights
Insights
Unlucky 13: Top Clinical Trial Failures of 2018
February 2019 Vol. 39 No. 2
Filtration Focuses on Capacity and Concentration Pain Points
February 2019 Vol. 39 No. 2
Bispecific, Multispecific Antibodies Grapple with Cancer
February 2019 Vol. 39 No. 2
Tissue Engineering Market in the U.S.
February 2019 Vol. 39 No. 2
Tumor Microenvironments Are Target-Rich Environments
A-Lists
Insights
Unlucky 13: Top Clinical Trial Failures of 2018
February 2019 Vol. 39 No. 2
10 Takeover Targets to Watch in 2019
Insights
Top 10 Global Biopharma IPOs of 2018
A-Lists
5 Biopharma Trends to Watch in 2019
A-Lists
Top 10 RNA-Based Biopharmas of 2018
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
News
Simple Cocktail Converts Astrocytes to Neurons
News
AbbVie to Co-Develop Teneobio’s Lead Candidate for Multiple Myeloma, Gains Acquisition…
News
Studying Malaria Transcriptomics Directly from Patients
News
Heightened Cocaine Addiction and Motivation in Women Linked to Hormones
Magazine
January 2019 Vol. 39 No. 1
All Aboard the Genome Express
January 2019 Vol. 39 No. 1
Advancing Precision Medicine Using Cloud-Based Informatics
January 2019 Vol. 39 No. 1
Taking Aim at Target ID and Validation
January 2019 Vol. 39 No. 1
CRISPR’s China Crisis
January 2019 Vol. 39 No. 1
PATH: New Organization Fostering AI, Automation and Healthcare
Resources
All
Videos
Webinars
eBooks
Podcasts
Events
New Products
Best of the Web
Best Apps
BioPerspectives
Webinars
Biology by Design: Applying Gigabases of DNA to Bioengineering
Multiplexing
Multiplexing Phenotype and Function for More Biologically Relevant Insights
February 2019 Vol. 39 No. 2
Microplate
February 2019 Vol. 39 No. 2
Micropumps
Subscribe
Create a Free Account
Log In
Get the GEN Mobile App
Get GEN Magazine
Get GEN eNewsletters
Search
Home
Authors
Posts by Sue Pearson
Sue Pearson
45 POSTS
0 COMMENTS
Ph.D. Freelance Writer GEN
Gene Therapy
U.K. Continues to Connect the Dots in Cell And Gene Therapy
Insights
The Netherlands Ups Its Biopharma Game
Insights
Brexit’s Effect on U.K. Life Sciences
Insights
Gene Therapy for Rare Diseases
Insights
BioTrinity Conference Focuses on NextGen Healthcare
Insights
Why is Adaptive Manufacturing of Biologics Difficult?
Uncategorized
UK Biotechs Present Novel Technologies at BioTrinity 2017
Insights
Screening Innovations and 3D Cell Culture Assay Developments Showcased at ELRIG
Insights
Will Cell and Gene Therapies Reach a Tipping Point?
Insights
Translating Innovation into Therapies
1
2
3
...
5
Page 1 of 5
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
